Innovative Licensing and Access Pathway
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Read the news from Medicines and Healthcare products Regulatory Agency updated on 24 January 2022.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (15 mars 2022). Innovative Licensing and Access Pathway. ELSIBI. Consulté le 7 octobre 2026 à l’adresse https://doi.org/10.58079/o5w1
